Product Images Donepezil Hydrochloride

The text provides a graph showing the cumulative percentage of patients who have been treated with Donepezil Hydrochloride 10 mg/day and placebo, and their ADCS-ADL change from Baseline, which suggests an effectiveness comparison between the two treatments.*

This appears to be a graph showing the cumulative percentage of patients and their SIB (Severe Impairment Battery) scores. The x-axis shows the SIB change from baseline, and the y-axis shows the cumulative percentage of patients. The graph shows that 100% of patients had a score of 60 or below on the SIB Change from Baseline, and that around 20% of patients had a score of 0.*

The text is not-available.*

This is a description of medication containing Donepezil Hydrochloride in tablet form produced by Aurobido Pharma USA. Each coated tablet contains 5mg of the drug. The recommended dosage is not available and is specified in the accompanying prescription. The tablets are allowed to be transported within a temperature range of 15° to 30°C (50-85°F), regulated by the USP. It should be kept in a container specified by the USP during dispensing. The production facility is based in India.*

This is a medication called Donepezil Hydrochloride Tablets USP, distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 5mg of Donepezil hydrochloride USP, and the usual dosage can be found in the accompanying prescribing information. It comes in a unit-dose package that is not child-resistant, so a container that is child-resistant should be used, especially for outpatient use. It should be stored at a temperature between 20°C to 25°C, with permitted excursions between 15°C to 30°C. The National Drug Code (NDC) for this product is 65862-325-10.*

This is a description for Donepezil Hydrochloride LS tablets which are distributed by Aurobindo Pharma USA. The usual dosage is mentioned in the accompanying prescription information. The tablets are made in India and come in a container. The tablets should be stored at room temperature and it is allowed to keep them at temperatures ranging from 15°C to 30°C. The package includes 100 tablets of Donepezil Hydrochloride LS. There is also a reference to a USP controlled excursion. The rest of the text is not readable due to errors.*

This is information about Donepezil Hydrochloride Tablets USP, containing 140 tablets per unit dose package. Each film-coated tablet contains 10 mg of Donepezil hydrochloride USP. The usual dosage is mentioned. This package is not child-resistant, so a child-resistant container should be used if dispensed for outpatient use. It is stored at controlled room temperature as per USP guidelines. This package is distributed by Aurobindo Pharma USA, Inc. and made in India. The code TS/DRUGS/9/1003 SWe5862152614 can be seen at the end.*

This is a table showing the percentage of patients who were given either donepezil hydrochloride (at 5 or 10 mg per day) or a placebo and then rated as either improved, minimally improved, no change, minimally worse, worse or markedly worse using the CIBIC-plus rating. There is also a graph showing the percentages at each level of improvement.*

This is clinical trial data showing the mean change from baseline of SIB (Severe Impairment Battery) score after 3 months of drug treatment between patients who received Donepezil Hydrochloride 10 mg/day and those who received placebo. There is no information about the actual values or statistical significance of the results.*

The text describes a chart or graph showing the cumulative percentage of patients who took 10mg/day of Donepazil Hydrochloride compared with a placebo. The chart also shows the percentage change in SIB (Severe Impairment Battery) from baseline at different time intervals.*